217 Users Online
Temporary Cardiac Pacing Wires Leads Market Segmented By Cardiac Pacing Wires and Cardiac Pacing Leads for Cardiothoracic Surgeries, Acute Myocardial Infarction, Bradycardia, Heart Blocks, Congestive Heart Failure (CHF), and Sick Sinus Syndrome By Epicardial Pacing, Transvenous Pacing, and Transcutaneous Pacing Technique
The temporary cardiac pacing wires & leads market is largely dominated by the top three manufacturers of these products who are competing on the basis of pricing in the market and have a different regional presence in the temporary cardiac pacing wires & leads market. Major manufacturers of temporary cardiac pacing wires & leads are engaging in expansion through acquisitions, partnerships and collaborations. Companies, such as Medtronic Plc., Becton, Dickinson and Company and Abbott Laboratories, hold more than 55% revenue share in the global temporary cardiac pacing wires & leads market. These companies are continuously making efforts to expand their product portfolio in the temporary cardiac pacing wires & leads market as well as their regional presence. By undertaking acquisitions, collaborations and partnerships, manufacturers are focusing on improving their regional footprints.
Recent and continuing development in radiotherapy, gene therapy and the technologies of imaging, material and devices & advancements in techniques for implementation have expanded the options for the treatment of temporary cardiac pacing.
Minimally invasive techniques have become an integral part of treatment and are widely accepted in cardiac surgery, which creates an extensive opportunity for the treatment of bradycardia and other cardiovascular surgeries. This is expected to drive the temporary cardiac pacing wires & leads market.
The ageing population is prone to different types of cardiovascular disease, which is expected to boost the need for surgeries and this is contributing to the demand for temporary cardiac pacing wires & leads.
The increasing requirement for pacing for the ageing population during surgeries, coupled with improved life expectancies, has created enormous opportunities for manufactures.
Technology and insertion techniques for temporary cardiac pacing have undergone remarkable development over the past few years. Significant advancements and the innovation of new products for temporary pacing has created opportunities for the temporary cardiac pacing wires and leads market during the forecast period.
Increased adoption of various types of leads and wires (bipolar & quadripolar) over traditional leads for epicardial and transvenous pacing for the treatment of postoperative bradycardia and acute myocardial infraction are also among the factors expected to drive the temporary cardiac pacing wires and leads market in the near future.
Increase in the number of cardiothoracic surgeries, mostly among the geriatric population, is forecasted to significantly boost the number of cardiothoracic procedures that are performed, even if incidence rates continue to decline. This is expected to drive the market for temporary cardiac pacing wires and leads in the near future.
The increasing number of cardiac surgeries & post-operative symptoms such as bradycardia and the increased usage of temporary pacing for the treatment of atrial fibrillation, which reduces or prevents symptomatic bradycardia, has proven to be advantageous, and this is expected to boost the temporary cardiac pacing wires and leads market.
The cardiovascular field is rapidly evolving due to advancements in the technologies that have emerged in a span of several years. These advancements have been spurred by the availability of low-power electronics, improved catheter delivery systems and high-density batteries.
As the number of cardiac surgeries is increasing, the risk associated with cardiac surgeries is decreasing and so is the cost associated with the treatment of bradycardia and acute myocardial infraction. Hence, there are significant growth opportunities for providers as well as players in the temporary cardiac pacing wires & leads market.
The competition section of the temporary cardiac pacing wires & leads market features the profiles of key players operating in the industry based on their company dashboard, differential strategies, market shares, marketing approach and product offerings. Some of the key players included in this report are Medtronic Plc., Becton, Dickinson and Company (C.R. Bard), B. Braun Melsungen AG, Abbott Laboratories (St. Jude Medical), Edwards Lifesciences Corporation, Teleflex Incorporated, OSCOR Inc., Vance Street Capital LLC (A&E Medical Corporation), OSYPKA AG and BioTrace Medical Inc.
Medtronic Plc., OSCOR Inc. and Teleflex Incorporated, offer a range of products in dermatology devices, which include unipolar, bipolar, quadripolar pacing wires and unipolar & bipolar leads.
The key manufacturers of temporary cardiac pacing wires & leads are focusing on manufacturing technologically advanced products to enhance efficiency and patient compliance.
Temporary cardiac pacing involves electrical cardiac stimulation for the treatment bradyarrhythmia until it gets resolved or until long-term therapy can be initiated. The purpose of temporary pacing is to re-establish circulatory integrity and normal hemodynamics that are acutely compromised by a slow or fast heart rate. Temporary cardiac pacing wires are cardiovascular devices that are used during a medical emergency or a lifesaving procedure that sends an electric current to the heart to get the heart beat back to normal pace in case of any abnormalities in the rhythm.
These devices are available in various forms, which include Uni-Polar, Bi-Polar and Quadri-Polar. In surgical procedures, wires are inserted through the chest or through any large vein in the peripheral region, which directly connects to the heart. These wires are connected to an external pacemaker/pacing box, which controls the flow of current to the heart and brings the rhythm back to normal pace. Temporary cardiac pacing can be used for several days or weeks.
The company conducted a research study on the temporary cardiac pacing wires & leads market for the forecast period 2016 to 2026. The temporary cardiac pacing wires & leads market report offers a comprehensive evaluation of the business opportunities prevailing in the temporary cardiac pacing wires & leads market, along with insights on the prices, current trends and reimbursement scenario.
The report offers a comprehensive taxonomy of the temporary cardiac pacing wires & leads market based on product type, application, technique, age group, end user and region. Temporary cardiac pacing wires & leads, such as wires and leads, are used for a variety of applications, which include cardiothoracic surgeries, acute myocardial infarction, bradycardia, heart blocks, Congestive Heart Failure (CHF), sick sinus syndrome, etc. However, temporary cardiac pacing leads, such as bi polar leads, are used for the pacing of the dual chamber of the heart. There are different types of wires & leads, and their usage depends upon the technique used. By application type, the temporary cardiac pacing wires & leads market is segmented into cardiothoracic surgeries, acute myocardial infarction, bradycardia, heart blocks, Congestive Heart Failure (CHF) and sick sinus syndrome.
By technique type, the temporary cardiac pacing wires & leads market is segmented into epicardial pacing, transvenous pacing and transcutaneous pacing. By age group, the temporary cardiac pacing wires & leads market is segmented into paediatric and adult. End-use segments in the temporary cardiac pacing wires & leads market, which are a part of this temporary cardiac pacing wires & leads market report, include hospitals and independent catheterisation labs. The temporary cardiac pacing wires & leads market has been analysed across the regions North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding China, China and Middle East & Africa (MEA).
Some of the additional questions addressed in this report on the temporary cardiac pacing wires & leads market have been listed below: